Acetaminophen reduces mitochondrial dysfunction during early cerebral postischemic reperfusion in rats

Brain Research

Volumn 1319, Issue , 2010, Pages 142-154

  Baliga, Sunanda S ^a   Jaques Robinson, Kathryn M ^a   Hadzimichalis, Norell M ^a   Golfetti, Roseli ^a   Merrill, Gary F ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Acetaminophen; Apoptosis; Mitochondria; Stroke

Indexed keywords

CASPASE 9; CYTOCHROME C; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN PROTECTION; BRAIN TISSUE; CAROTID ARTERY OBSTRUCTION; CELL FRACTIONATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HYPOTENSION; HYPOVOLEMIA; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TISSUE INJURY; WESTERN BLOTTING;

ACETAMINOPHEN; ANIMALS; APOPTOSIS; BRAIN; BRAIN ISCHEMIA; CAROTID ARTERY DISEASES; CASPASE 9; CYTOCHROMES C; DISEASE MODELS, ANIMAL; HYPOTENSION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL SWELLING; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TIME FACTORS;

RATTUS;

EID: 76849094630     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.01.013     Document Type: Article

References (64)

1. Adams Jr. H.P., del Zoppo G., Alberts M.J., Bhatt D.L., Brass L., Furlan A., Grubb R.L., Higashida R.T., Jauch E.C., Kidwell C., Lyden P.D., Morgenstern L.B., Qureshi A.I., Rosenwasser R.H., Scott P.A., and Wijdicks E.F. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38 (2007) 1655-1711
2. Bahcekapili N., Uzum G., Gokkusu C., Kuru A., and Ziylan Y.Z. The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats. Life Sci. 80 (2007) 1245-1251
3. Bertolini A., Ferrari A., Ottani A., Guerzoni S., Tacchi R., and Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 12 (2006) 250-275
4. Bisaglia M., Venezia V., Piccioli P., Stanzione S., Porcile C., Russo C., Mancini F., Milanese C., and Schettini G. Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation. Neurochem. Int. 41 (2002) 43-54
5. Bozzola, J.J., Russell, L.D., NetLibrary Inc., 1999. Electron Microscopy Principles and Techniques for Biologists. Vol., ed.^eds. Jones and Bartlett, Sudbury, Mass., pp. xxiii, 670 pp.
6. Campanella M., Sciorati C., Tarozzo G., and Beltramo M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33 (2002) 586-592
7. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow. Metab. 21 (2001) 2-14
8. Charriaut-Marlangue C., Margaill I., Represa A., Popovici T., Plotkine M., and Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J. Cereb. Blood Flow. Metab. 16 (1996) 186-194
9. Cheng Y.D., Al-Khoury L., and Zivin J.A. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 1 (2004) 36-45
10. Chu L.S., Fang S.H., Zhou Y., Yu G.L., Wang M.L., Zhang W.P., and Wei E.Q. Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats. Acta Pharmacol. Sin. 28 (2007) 763-772
11. Cooper H.K., Zalewska T., Kawakami S., Hossmann K.A., and Kleihues P. The effect of ischaemia and recirculation on protein synthesis in the rat brain. J. Neurochem. 28 (1977) 929-934
12. Cossarizza A., Baccarani-Contri M., Kalashnikova G., and Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5, 5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197 (1993) 40-45
13. Dippel D.W., van Breda E.J., van Gemert H.M., van der Worp H.B., Meijer R.J., Kappelle L.J., and Koudstaal P.J. Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial. Stroke 32 (2001) 1607-1612
14. Dippel D.W., van Breda E.J., van der Worp H.B., van Gemert H.M., Meijer R.J., Kappelle L.J., and Koudstaal P.J. Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]. BMC Cardiovasc Disord. 3 (2003) 2
15. Friedlander R.M. Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 348 (2003) 1365-1375
16. Fujimura M., Morita-Fujimura Y., Murakami K., Kawase M., and Chan P.H. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow. Metab. 18 (1998) 1239-1247
17. Galluzzi L., Blomgren K., and Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat. Rev. Neurosci. 10 (2009) 481-494
18. Golfetti R., VanDyke K., Rork T., Spiler N., and Merrill G. Acetaminophen in the post-ischemia reperfused myocardium. Exp. Biol. Med. (Maywood) 227 (2002) 1031-1037
19. Hadzimichalis N.M., Baliga S.S., Golfetti R., Jaques K.M., Firestein B.L., and Merrill G.F. Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H3348-H3355
20. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., and Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001) 3017-3023
21. Jover T., Tanaka H., Calderone A., Oguro K., Bennett M.V., Etgen A.M., and Zukin R.S. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J. Neurosci. 22 (2002) 2115-2124
22. Kaasik A., Safiulina D., Zharkovsky A., and Veksler V. Regulation of mitochondrial matrix volume. Am. J. Physiol. Cell Physiol. 292 (2007) C157-C163
23. Kang M.H., and Reynolds C.P. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin. Cancer Res. 15 (2009) 1126-1132
24. Kleindorfer D., Lindsell C.J., Brass L., Koroshetz W., and Broderick J.P. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 39 (2008) 924-928
25. Krajewska M., Rosenthal R.E., Mikolajczyk J., Stennicke H.R., Wiesenthal T., Mai J., Naito M., Salvesen G.S., Reed J.C., Fiskum G., and Krajewski S. Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitation. Exp. Neurol. 189 (2004) 261-279
26. Li Y., Chopp M., Jiang N., Zhang Z.G., and Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke 26 (1995) 1252-1257 discussion 1257-8
27. Li Y., Chopp M., Powers C., and Jiang N. Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Res. 765 (1997) 301-312
28. Li Y., Powers C., Jiang N., and Chopp M. Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat. J. Neurol. Sci. 156 (1998) 119-132
29. Lobysheva N.V., Tonshin A.A., Selin A.A., Yaguzhinsky L.S., and Nartsissov Y.R. Diversity of neurodegenerative processes in the model of brain cortex tissue ischemia. Neurochem. Int. 54 (2009) 322-329
30. Locke C.J., Fox S.A., Caldwell G.A., and Caldwell K.A. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease. Neurosci. Lett. 439 (2008) 129-133
31. Maharaj H., Maharaj D.S., and Daya S. Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity. Metab. Brain Dis. 21 (2006) 189-199
32. Mathur A., Hong Y., Kemp B.K., Barrientos A.A., and Erusalimsky J.D. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc. Res. 46 (2000) 126-138
33. Merrill G., McConnell P., Vandyke K., and Powell S. Coronary and myocardial effects of acetaminophen: protection during ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H2631-H2638
34. Merrill G.F., and Goldberg E. Antioxidant properties of acetaminophen and cardioprotection. Basic Res. Cardiol. 96 (2001) 423-430
35. Merrill G.F., Rork T.H., Spiler N.M., and Golfetti R. Acetaminophen and myocardial infarction in dogs. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H1913-H1920
36. Mohr J.P. Stroke: Pathophysiology, Diagnosis, and Management (2004), Churchill Livingstone, Philadelphia, PA Vol
37. Nakka V.P., Gusain A., Mehta S.L., and Raghubir R. Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol. Neurobiol. 37 (2008) 7-38
38. Nowak Jr. T.S., Fried R.L., Lust W.D., and Passonneau J.V. Changes in brain energy metabolism and protein synthesis following transient bilateral ischemia in the gerbil. J. Neurochem. 44 (1985) 487-494
39. Prescott L.F. Paracetamol: past, present, and future. Am. J. Ther. 7 (2000) 143-147
40. Rami A., Bechmann I., and Stehle J.H. Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Prog. Neurobiol. 85 (2008) 273-296
41. Reers M., Smith T.W., and Chen L.B. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry. 30 (1991) 4480-4486
42. Reers M., Smiley S.T., Mottola-Hartshorn C., Chen A., Lin M., and Chen L.B. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 260 (1995) 406-417
43. Rohn T.T., Vyas V., Hernandez-Estrada T., Nichol K.E., Christie L.A., and Head E. Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J. Neurosci. 28 (2008) 3051-3059
44. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S.M., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C., Roger V., Sorlie P., Steinberger J., Thom T., Wilson M., and Hong Y. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
45. Schinzel A.C., Takeuchi O., Huang Z., Fisher J.K., Zhou Z., Rubens J., Hetz C., Danial N.N., Moskowitz M.A., and Korsmeyer S.J. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12005-12010
46. Simpkins J.W., and Dykens J.A. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res. Rev. 57 (2008) 421-430
47. Slemmer J.E., Shacka J.J., Sweeney M.I., and Weber J.T. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr. Med. Chem. 15 (2008) 404-414
48. Smith M.L., Bendek G., Dahlgren N., Rosen I., Wieloch T., and Siesjo B.K. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol. Scand. 69 (1984) 385-401
49. Sugawara T., and Chan P.H. Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid. Redox Signal. 5 (2003) 597-607
50. Sugawara T., Fujimura M., Noshita N., Kim G.W., Saito A., Hayashi T., Narasimhan P., Maier C.M., and Chan P.H. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx. 1 (2004) 17-25
51. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Brenner C., Larochette N., Prevost M.C., Alzari P.M., and Kroemer G. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189 (1999) 381-394
52. Szeto H.H. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J. 8 (2006) E521-E531
53. Taoufik E., and Probert L. Ischemic neuronal damage. Curr. Pharm. Des. 14 (2008) 3565-3573
54. Tedeschi H., and Harris D.L. The osmotic behavior and permeability to non-electrolytes of mitochondria. Arch. Biochem. Biophys. 58 (1955) 52-67
55. Tripathy D., and Grammas P. Acetaminophen inhibits neuronal inflammation and protects neurons from oxidative stress. J. Neuroinflammation. 6 (2009) 10
56. Tsujimoto Y., Nakagawa T., and Shimizu S. Mitochondrial membrane permeability transition and cell death. Biochim. Biophys. Acta 1757 (2006) 1297-1300
57. Wang K.X., Shi Y., and Denhardt D.T. Osteopontin regulates hindlimb-unloading-induced lymphoid organ atrophy and weight loss by modulating corticosteroid production. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14777-14782
58. Yang Y., Shuaib A., and Li Q. Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method. J. Neurosci. Methods. 84 (1998) 9-16
59. Yousuf S., Atif F., Ahmad M., Hoda N., Ishrat T., Khan B., and Islam F. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 1250 (2009) 242-253
60. Yuan J. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis 14 (2009) 469-477
61. Zhang H., Li Q., Li Z., Mei Y., and Guo Y. The protection of Bcl-2 overexpression on rat cortical neuronal injury caused by analogous ischemia/reperfusion in vitro. Neurosci. Res. 62 (2008) 140-146
62. Zhang Y. Clonidine preconditioning decreases infarct size and improves neurological outcome from transient forebrain ischemia in the rat. Neuroscience 125 (2004) 625-631
63. Zhang Z.G., Chopp M., Zaloga C., Pollock J.S., and Forstermann U. Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke 24 (1993) 2016-2021 discussion 2021-2
64. Zhu Y.Z., Chong C.L., Chuah S.C., Huang S.H., Nai H.S., Tong H.T., Whiteman M., and Moore P.K. Cardioprotective effects of nitroparacetamol and paracetamol in acute phase of myocardial infarction in experimental rats. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H517-H524